Actuate Therapeutics, Inc.

Actuate Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapies for cancers with high unmet needs. Their lead drug, elraglusib, is a small molecule GSK-3 inhibitor that targets multiple molecular pathways involved in tumor growth and resistance to traditional cancer treatments. Elraglusib has shown potential in treating various cancers, including pancreatic cancer and Ewing sarcoma, and has received Fast Track and Orphan Drug designations from the FDA for pancreatic cancer.

Actuate is driven by a passion to give patients with hard-to-treat cancers the opportunity to live longer and better lives. Their research is focused on delivering therapies with minimal adverse effects, aiming to improve clinical outcomes for patients suffering from advanced and challenging cancers. The company actively seeks partnerships with academic and scientific organizations to further advance their research and bring innovative therapies to patients.

Actuate Therapeutics does not currently have any open positions advertised. Therefore, information on their job flexibility is not available.

Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for cancers with high unmet needs. They aim to provide patients with hard-to-treat cancers the opportunity to live longer and better by developing therapies that have the potential to slow, stop, or shrink tumors with minimal adverse effects. Their lead drug, elraglusib, targets multiple molecular pathways in cancer that are involved in promoting tumor growth and resistance to conventional cancer drugs, and it is also emerging as a mediator of anti-tumor immunity.

Actuate Therapeutics, Inc. promotes a culture of scientific innovation, integrity, ethics, and inclusion. They are passionate about their work and dedicated to improving patient outcomes, emphasizing the importance of curiosity, drive, and a commitment to making a difference. This is reflected in their dedication to pushing further in their research, collaborating with academic and scientific organizations, and ensuring a diverse and ethical workplace.